E
ProPhase Labs, Inc. PRPH
$0.3396 -$0.0107-3.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -217.98% -164.97% -502.47% -461.97% -190.90%
Total Depreciation and Amortization 2.67% 34.06% 36.44% 34.94% 27.86%
Total Amortization of Deferred Charges 1,025.00% 967.01% 919.57% 1,021.74% 3,200.00%
Total Other Non-Cash Items 155.50% -41.46% -45.75% -49.34% -46.46%
Change in Net Operating Assets 321.50% 99.44% 89.44% 52.57% -54.88%
Cash from Operations -47.53% -42.58% -405.07% -300.03% -141.64%
Capital Expenditure 56.53% 59.90% 43.73% 24.99% 46.82%
Sale of Property, Plant, and Equipment -- -- 87.50% -- --
Cash Acquisitions -- 100.00% 100.00% 100.00% --
Divestitures -- -- -- -- --
Other Investing Activities 0.13% 203.43% 855.84% 314.59% 122.66%
Cash from Investing 276.92% 123.45% 126.63% 134.79% 34.09%
Total Debt Issued 29.76% 9.66% -49.11% -67.63% --
Total Debt Repaid -- 55.21% 83.96% 96.64% --
Issuance of Common Stock 532.83% 285.33% -- -- --
Repurchase of Common Stock -- 100.00% 100.00% 99.67% 38.01%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 146.40% 300.66% 206.65% 137.08% 122.12%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 87.59% 99.33% 90.07% 48.02% -1,762.97%